| Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: a Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial S Pasquali, E Palmerini, V Quagliuolo, J Martin‐Broto, A Lopez‐Pousa, ... Cancer 128 (1), 85-93, 2022 | 60 | 2022 |
| Prevalence of fatigue in head and neck cancer survivors P Bossi, P Di Pede, M Guglielmo, R Granata, S Alfieri, NA Iacovelli, ... Annals of Otology, Rhinology & Laryngology 128 (5), 413-419, 2019 | 41 | 2019 |
| Locally advanced epithelial sinonasal tumors: the impact of multimodal approach E Orlandi, S Cavalieri, R Granata, P Nicolai, P Castelnuovo, C Piazza, ... The Laryngoscope 130 (4), 857-865, 2020 | 33 | 2020 |
| Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse C Rusconi, CY Cheah, TA Eyre, D Tucker, P Klener, E Giné, L Crucitti, ... Blood, The Journal of the American Society of Hematology 140 (17), 1907-1916, 2022 | 24 | 2022 |
| Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? F Nichetti, FS Falvella, R Miceli, S Cheli, R Gaetano, G Fucà, G Infante, ... The Pharmacogenomics Journal 19 (5), 465-472, 2019 | 23 | 2019 |
| Long‐term outcome of re‐irradiation for recurrent or second primary head and neck cancer: A multi‐institutional study of AIRO—Head and Neck working group E Orlandi, P Bonomo, L Ferella, E D'Angelo, M Maddalo, D Alterio, ... Head & Neck 41 (10), 3684-3692, 2019 | 19 | 2019 |
| Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy M Siano, G Infante, C Resteghini, MC Cau, S Alfieri, C Bergamini, ... Oral oncology 69, 33-37, 2017 | 18 | 2017 |
| Predictors of patient-reported dysphagia following IMRT plus chemotherapy in oropharyngeal cancer E Orlandi, R Miceli, G Infante, A Mirabile, D Alterio, M Cossu Rocca, ... Dysphagia 34, 52-62, 2019 | 17 | 2019 |
| Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network AM Frezza, A Napolitano, R Miceli, G Badalamenti, A Brunello, ... ESMO open 6 (2), 100083, 2021 | 14 | 2021 |
| Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors F Pietrantonio, S Lonardi, F Corti, G Infante, ME Elez, M Fakih, ... Journal for immunotherapy of cancer 9 (8), 2021 | 14 | 2021 |
| Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer … FS Falvella, C Cremolini, R Miceli, F Nichetti, S Cheli, C Antoniotti, ... The Pharmacogenomics Journal 17 (4), 331-336, 2017 | 13 | 2017 |
| Failure of further validation for survival nomograms in oropharyngeal cancer: issues and challenges P Bossi, R Miceli, R Granata, S Naimo, G Infante, LD Locati, NA Iacovelli, ... International Journal of Radiation Oncology* Biology* Physics 100 (5), 1217-1221, 2018 | 9 | 2018 |
| Preoperative capecitabine, oxaliplatin, and irinotecan in resectable gastric or gastroesophageal junction cancer: Pathological response as primary endpoint and FDG-PET predictions R Berenato, F Morano, F Pietrantonio, C Cotsoglou, M Caporale, ... Oncology 93 (5), 279-286, 2017 | 9 | 2017 |
| Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials P Bossi, R Miceli, M Benasso, R Corvò, A Bacigalupo, G Sanguineti, ... Head & Neck 40 (12), 2648-2656, 2018 | 7 | 2018 |
| Aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer: profiles of psychological symptoms and quality of life in different patient clusters C Borreani, S Alfieri, G Infante, R Miceli, P Mariani, M Bosisio, C Vernieri, ... Oncology 99 (2), 84-95, 2021 | 6 | 2021 |
| Live or Heat-Killed Lactobacillus rhamnosus Aerosolization Decreases Adenomatous Lung Cancer Development in a Mouse Carcinogen-Induced Tumor Model V Le Noci, G Bernardo, G Manenti, G Infante, D Khaleghi Hashemian, ... International Journal of Molecular Sciences 23 (21), 12748, 2022 | 5 | 2022 |
| Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment M Shkodra, C Brunelli, E Zecca, G Infante, R Miceli, M Caputo, P Bracchi, ... Palliative medicine 36 (9), 1396-1407, 2022 | 5 | 2022 |
| Sample size and predictive performance of machine learning methods with survival data: A simulation study G Infante, R Miceli, F Ambrogi Statistics in Medicine 42 (30), 5657-5675, 2023 | 3 | 2023 |
| Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a … M Siano, C Resteghini, MC Cau, S Alfieri, C Bergamini, R Granata, ... European Journal of Cancer 51, S578-S578, 2015 | 3 | 2015 |
| Cholesterol de novo Biosynthesis in Paired Samples of Breast Cancer and Adjacent Histologically Normal Tissue: Association with Proliferation Index, Tumor Grade, and Recurrence … D Coradini, F Ambrogi, G Infante Archives of Breast Cancer 10 (2), 187-199, 2023 | 2 | 2023 |
